semaglutide shortage news november 2025 Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders Weight-loss jab could be made

GLP-1-based medications such as semaglutide and the dual GIP/GLP-1 receptor agonist tirzepatide have a well-established clinical evidence base for weight management

You can read my article on overcoming anxiety with Hashimotos for more details

Brand-name semaglutide options Lavender Sky also provides access to FDA-approved brand-name semaglutide

Since then, several GLP-1s for obesity have been approved for new indications, such as secondary cardiovascular risk reduction (Wegovy), sleep apnea (Zepbound) and metabolic dysfunction-associated steatohepatitis, or MASH (Wegovy)

Zepbound is an FDA-approved prescription medication that belongs to the class of GLP-1 receptor agonists

Muscle damage , which is characterised by increased protein turnover in both muscles and the rest of the body, and the oxidation of amino acids during and after exercise increase a persons need for protein